Hepatocellular carcinoma: Morphological spectrum and subtyping as per the World Health Organization classification on FNA biopsy with cell block samples

IF 3.2 3区 医学 Q3 ONCOLOGY Cancer Cytopathology Pub Date : 2025-03-05 DOI:10.1002/cncy.70009
Bhawana Dhiman MD, Reetu Kundu MD, Suvradeep Mitra MD, Naveen Kalra MD, Madhumita Premkumar MD, DM, Ajay Kumar Duseja MD, DM, Radhika Srinivasan MD, PhD
{"title":"Hepatocellular carcinoma: Morphological spectrum and subtyping as per the World Health Organization classification on FNA biopsy with cell block samples","authors":"Bhawana Dhiman MD,&nbsp;Reetu Kundu MD,&nbsp;Suvradeep Mitra MD,&nbsp;Naveen Kalra MD,&nbsp;Madhumita Premkumar MD, DM,&nbsp;Ajay Kumar Duseja MD, DM,&nbsp;Radhika Srinivasan MD, PhD","doi":"10.1002/cncy.70009","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Hepatocellular carcinoma (HCC) may be diagnosed and further subclassified in surgical specimen as per the recent World Health Organization (WHO) classification into several distinct subtypes with prognostic implications. The aim of this study was to apply this WHO classification on fine-needle aspiration biopsy (FNAB) samples of HCC and describe their features.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This was a retrospective analysis of all ultrasound-guided FNAB of liver mass lesions in patients with suspected HCC (<i>n</i> = 164) over a 7-year period. Detailed morphological assessment of cytopathological features and grading was done and correlated with each other. HCC was subtyped further in cases with available cell blocks (<i>n</i> = 126).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 164 cases of HCC were evaluated on FNAB with age range of 18–88 years (mean, 60 years), and with 140 (85.4%) male and 24 (14.6%) female patients. Grading performed on 160 cases of HCC (after excluding fibrolamellar HCC) revealed 23 well differentiated, 127 moderately differentiated, and 10 poorly differentiated HCCs. Subtyping was feasible in 126 cases, of which 26 cases (20.6%) showed specific subtypes that were steatohepatitic (8), lymphocyte-rich (8), fibrolamellar (4), neutrophil-rich (3), macrotrabecular massive (2), and clear cell HCC (1) with remaining cases (100) being conventional HCC, no special type.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The study demonstrates the feasibility of subtyping HCC (as per the current WHO classification) for the first time on FNAB with cell blocks that carries implication for prognostication and emphasizes the importance of obtaining tissue diagnosis by FNAB with cell blocks.</p>\n </section>\n </div>","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":"133 4","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Cytopathology","FirstCategoryId":"3","ListUrlMain":"https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncy.70009","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Hepatocellular carcinoma (HCC) may be diagnosed and further subclassified in surgical specimen as per the recent World Health Organization (WHO) classification into several distinct subtypes with prognostic implications. The aim of this study was to apply this WHO classification on fine-needle aspiration biopsy (FNAB) samples of HCC and describe their features.

Methods

This was a retrospective analysis of all ultrasound-guided FNAB of liver mass lesions in patients with suspected HCC (n = 164) over a 7-year period. Detailed morphological assessment of cytopathological features and grading was done and correlated with each other. HCC was subtyped further in cases with available cell blocks (n = 126).

Results

A total of 164 cases of HCC were evaluated on FNAB with age range of 18–88 years (mean, 60 years), and with 140 (85.4%) male and 24 (14.6%) female patients. Grading performed on 160 cases of HCC (after excluding fibrolamellar HCC) revealed 23 well differentiated, 127 moderately differentiated, and 10 poorly differentiated HCCs. Subtyping was feasible in 126 cases, of which 26 cases (20.6%) showed specific subtypes that were steatohepatitic (8), lymphocyte-rich (8), fibrolamellar (4), neutrophil-rich (3), macrotrabecular massive (2), and clear cell HCC (1) with remaining cases (100) being conventional HCC, no special type.

Conclusion

The study demonstrates the feasibility of subtyping HCC (as per the current WHO classification) for the first time on FNAB with cell blocks that carries implication for prognostication and emphasizes the importance of obtaining tissue diagnosis by FNAB with cell blocks.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肝细胞癌:根据世界卫生组织对细胞块样本的FNA活检分类的形态学谱和亚型
背景肝细胞癌(HCC)可以被诊断出来,并根据最近世界卫生组织(WHO)的分类,在手术标本中进一步细分为几种具有预后意义的不同亚型。本研究的目的是将WHO分类应用于细针穿刺活检(FNAB) HCC样本,并描述其特征。方法回顾性分析7年来所有超声引导下疑似HCC患者(n = 164)肝肿块病变的FNAB。对细胞病理特征和分级进行了详细的形态学评价,并相互关联。在有可用细胞块的病例中,HCC进一步分型(n = 126)。结果FNAB检测HCC共164例,年龄18 ~ 88岁,平均60岁,其中男性140例(85.4%),女性24例(14.6%)。对160例HCC进行分级(排除纤维板层性HCC),结果显示23例为高分化,127例为中度分化,10例为低分化HCC。126例可进行亚型分型,其中26例(20.6%)表现出特异性亚型,分别为脂肪肝型(8例)、富淋巴细胞型(8例)、纤维板层型(4例)、富中性粒细胞型(3例)、大小梁块状(2例)和透明细胞型(1例),其余100例为常规HCC,无特殊类型。结论本研究首次证明了FNAB结合细胞块对HCC进行分型(按照WHO现行分类)的可行性,具有预测意义,并强调了FNAB结合细胞块获得组织诊断的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer Cytopathology
Cancer Cytopathology 医学-病理学
CiteScore
7.00
自引率
17.60%
发文量
130
审稿时长
1 months
期刊介绍: Cancer Cytopathology provides a unique forum for interaction and dissemination of original research and educational information relevant to the practice of cytopathology and its related oncologic disciplines. The journal strives to have a positive effect on cancer prevention, early detection, diagnosis, and cure by the publication of high-quality content. The mission of Cancer Cytopathology is to present and inform readers of new applications, technological advances, cutting-edge research, novel applications of molecular techniques, and relevant review articles related to cytopathology.
期刊最新文献
Clinical utility of oral cytology for detecting oral epithelial dysplasia or worse: A diagnostic meta-analysis. Navigating the International System for Reporting Serous Fluid Cytopathology in pericardial effusion: A meta-analysis. Artificial intelligence in nongynecologic cytology: A systematic review of current research and commercial tools. Testing insulin-like growth factor messenger RNA-binding protein 3 as a surrogate immunohistochemical marker for indeterminate thyroid nodules with THADA fusion in both cytologic and surgical specimens. High accuracy in detecting HER2-low status in FNA of primary and metastatic breast cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1